Government’s Drug Ban Sparks Outrage: Common Medications Like Paracetamol and Cetirizine Deemed ‘Irrational,’ Public Left in Shock
In a controversial move that has sent shockwaves through the medical and pharmaceutical sectors, the Indian government has banned 156 combination drugs, including widely used medications such as Paracetamol and Cetirizine. The decision, based on recommendations by the Drugs Technical Advisory Board (DTAB) and an Expert Committee, has raised serious questions about the rationale behind prohibiting such commonly prescribed drugs.
Adding fuel to the fire, the government is reportedly reviewing 34 multivitamins, potentially placing them under the chopping block as well. Critics argue that the sweeping ban could leave millions of patients without access to their regular medications, disrupting healthcare routines nationwide.
‘Irrational’ or Essential?
The Gazette notification claims the banned drugs lack therapeutic justification and pose risks to human health, labeling them as “irrational.” However, many healthcare professionals and patients are questioning the government’s judgment, citing decades of widespread use with minimal issues.
“Paracetamol is a staple in Indian households for managing fever and pain. Banning its combination drugs overnight feels like an overreach,” said a senior physician on the condition of anonymity.
The inclusion of multivitamins under review has further complicated matters. Multivitamins are often seen as harmless supplements, and their potential ban has left consumers and medical practitioners puzzled.
Industry Backlash
Pharmaceutical companies are bracing for massive losses, with experts estimating billions of rupees in revenue at stake. Industry insiders are accusing the government of taking an “overzealous” approach that disregards patient needs and market realities.
“The government’s reliance on expert committees without adequately consulting stakeholders undermines trust in such decisions,” said a leading pharmaceutical lobbyist.
Public Reaction
Patients across the country are voicing their concerns, especially those who rely on these combination drugs for chronic conditions. Social media is abuzz with criticism, with hashtags like #DrugBan and #HealthcareCrisis trending.
“This ban feels like a punishment for ordinary citizens who just want affordable and effective medication,” tweeted one user.
Uncertain Future
While the government defends its decision as being in the “larger public interest,” critics argue it sets a dangerous precedent. If popular and widely trusted drugs like Paracetamol combinations can be deemed harmful, what’s next?
As the debate rages on, the real impact of this decision will unfold in the coming weeks, leaving a nation questioning whether its healthcare system is truly prioritizing public welfare—or succumbing to bureaucracy.
AdChoices Opt-out 